Welcome to our dedicated page for GoHealth news (Ticker: $GOCO), a resource for investors and traders seeking the latest updates and insights on GoHealth stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GoHealth's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GoHealth's position in the market.
GoHealth, Inc. (NASDAQ: GOCO) reported Q1 2024 financial results with net revenues of $185.6 million, a slight increase year-over-year. Submissions increased to 216,148. Net loss improved to $21.3 million. Adjusted EBITDA decreased to $26.9 million. TTM cash flow from operations grew to $101.2 million. Regulatory updates show alignment with CMS guidelines. CEO and CFO optimistic about consumer-centric approach and long-term profitability.
GoHealth, Inc. to present at the RBC Capital Markets Global Healthcare Conference on May 15, 2024, at 2:05 p.m. Eastern Time. The presentation will be accessible via a live webcast and a replay will be available on GoHealth's Investor Relations website.